World Patient Safety Day
Safe care for life! On 17 September, we mark World Patient Safety Day. This year’s theme, “Safe care for life!”, focuses on the safety of care for people living with noncommunicable diseases — across prevention, diagnosis, treatment and long-term care. At Biokinetica, safety is at the heart of every clinical study we conduct. Many of […]
When Patient Recruitment Gets Complex, Execution Matters
In Early-Phase oncology, recruitment challenges are rarely solved by speed alone. Complex eligibility criteria, diverse tumor types, and demanding timelines require a coordinated approach built around expertise, collaboration, and patient engagement. Biokinetica’s case study highlights how our hospital-based clinical research team supported rapid recruitment and strong retention in a complex oncology DDI study through: • […]
Biokinetica at 35th Economic Forum in Karpacz
“Architecture of the New Order – Stability in Times of Change” The ending XXXV Economic Forum was an important space for dialogue about the future of the economy, health care, innovations, as well as the directions of development of the life sciences sector. For Biokinetica, represented by Marek Kiecana and Aleksander Kiecana, talks about clinical […]
Why a Hospital-Based Environment Matters in Early-Phase Oncology
In early-phase oncology, the clinical environment plays an important role in successful study execution. A hospital-based setting provides immediate access to specialist care, continuous medical oversight, and the infrastructure needed to support patients participating in complex Phase 1 studies. It also gives sponsors confidence that clinical decisions can be made quickly when needed. At Biokinetica, […]
Recruitment Speed Can Make a Real Difference
For sponsors running early-phase studies, recruitment speed can make a real difference. When a study requires a large number of healthy study participants, finding the right people — and having them ready when needed — can be a challenge. At Biokinetica, we combine access to a large pool of pre-profiled healthy study participants with structured […]
World Breast Cancer Research Day
Every advance in breast cancer care begins with research. On World Breast Cancer Research Day, we recognise the role of clinical research in driving earlier diagnosis, more targeted therapies, and better outcomes for patients. Progress in oncology doesn’t happen overnight—it is built through scientific collaboration, innovation, and the willingness of patients to participate in clinical […]
Biokinetica Behind The Scenes
A blood sample is more than a tube. In early-phase clinical trials, every sample provides valuable information about how an investigational therapy behaves in the body. That’s why what happens after collection is just as important as the collection itself. Behind the scenes, samples are processed according to strict protocol requirements and often within defined […]
Delivering Confidence in Early-Phase Cardiac Safety
What gives sponsors confidence in early-phase cardiac safety? It’s not just about collecting data. It’s about having the right technology, expertise, and oversight to turn cardiac signals into meaningful insight. At Biokinetica, continuous telemetry and real-time ECG monitoring provide clear visibility throughout the study. Advanced QTc modelling, automated signal detection, and experienced clinical teams help […]
Biokinetica Behind The Scenes
The first step in every clinical trial is a conversation. A signature on a consent form represents a participant’s decision to contribute to medical progress — after receiving clear information, having questions answered and understanding every aspect of the study. In Phase 1 clinical trials, where new therapies are evaluated for the first time in […]
World Lung Cancer Day
On August 1, we observe World Lung Cancer Day – an important opportunity to stand with patients, families, healthcare professionals, and researchers working to improve outcomes for people affected by lung cancer. Lung cancer remains one of the leading causes of cancer-related deaths worldwide. Continued research is essential to advancing innovative therapies and expanding treatment […]
